Meningococcal disease: clinical presentation and sequelae
- PMID: 22607896
- DOI: 10.1016/j.vaccine.2011.12.062
Meningococcal disease: clinical presentation and sequelae
Abstract
The clinical spectrum of invasive meningococcal disease is diverse with meningitis and/or septicaemia being the commonest modes of presentation. The severity of manifestations of meningococcal infection ranges from bacteraemia, associated with mild non-specific symptoms, to fulminant sepsis with multiorgan failure and death in approximately 10-15% of cases. Localised infections (such as conjunctivitis or septic arthritis) as well as chronic disease may be the sole clinical manifestations but can also lead to disseminated fulminant disease. Among survivors, disabling long-term sequelae can complicate meningococcal disease and result in potentially devastating effects on the quality of life of survivors, most of whom are infants, children and adolescents. The only rational approach to the prevention of meningococcal disease and the associated human suffering is through vaccination.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Clinical presentation of meningococcal disease in childhood.J Prev Med Hyg. 2012 Jun;53(2):116-9. J Prev Med Hyg. 2012. PMID: 23240173 Review.
-
The changing and dynamic epidemiology of meningococcal disease.Vaccine. 2012 May 30;30 Suppl 2:B26-36. doi: 10.1016/j.vaccine.2011.12.032. Epub 2011 Dec 15. Vaccine. 2012. PMID: 22178525 Review.
-
Considerations for controlling invasive meningococcal disease in high income countries.Vaccine. 2012 May 30;30 Suppl 2:B57-62. doi: 10.1016/j.vaccine.2011.12.093. Vaccine. 2012. PMID: 22607900 Review.
-
Challenges for development of meningococcal vaccines in infants and children.Expert Rev Vaccines. 2011 Mar;10(3):335-43. doi: 10.1586/erv.11.3. Expert Rev Vaccines. 2011. PMID: 21434801 Review.
-
[Death within Hours].Praxis (Bern 1994). 2019 Sep;108(13):877-882. doi: 10.1024/1661-8157/a003314. Praxis (Bern 1994). 2019. PMID: 31571546 German.
Cited by
-
Fulminant Neisseria meningitidis septicaemia with purpura fulminans requiring limb amputation.IDCases. 2019 Nov 28;19:e00673. doi: 10.1016/j.idcr.2019.e00673. eCollection 2020. IDCases. 2019. PMID: 31879595 Free PMC article.
-
The Host-Pathogen Interactions and Epicellular Lifestyle of Neisseria meningitidis.Front Cell Infect Microbiol. 2022 Apr 22;12:862935. doi: 10.3389/fcimb.2022.862935. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35531336 Free PMC article. Review.
-
Child with serogroup W135 primary meningococcal septic arthritis.BMJ Case Rep. 2019 Oct 15;12(10):e229510. doi: 10.1136/bcr-2019-229510. BMJ Case Rep. 2019. PMID: 31619399 Free PMC article.
-
Genomic surveillance of Neisseria meningitidis serogroup W in Portugal from 2003 to 2019.Eur J Clin Microbiol Infect Dis. 2022 Feb;41(2):289-298. doi: 10.1007/s10096-021-04371-7. Epub 2021 Nov 17. Eur J Clin Microbiol Infect Dis. 2022. PMID: 34787749
-
Sequence, distribution and chromosomal context of class I and class II pilin genes of Neisseria meningitidis identified in whole genome sequences.BMC Genomics. 2014 Apr 1;15:253. doi: 10.1186/1471-2164-15-253. BMC Genomics. 2014. PMID: 24690385 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical